Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer

Ann Surg Oncol. 2014 Jun;21(6):1998-2004. doi: 10.1245/s10434-014-3533-9. Epub 2014 Feb 11.

Abstract

Background: This study was designed to identify which are the best preoperative inflammation-based prognostic scores in terms of overall survival (OS) and disease-free survival (DFS) in patients with gastric cancer.

Methods: Between January 2004 and January 2013, 102 consecutive patients underwent resection for gastric cancer at S. Andrea Hospital, "La Sapienza", University of Rome. Their records were retrospectively reviewed.

Results: After a median follow up of 40.8 months (8-107 months), patients' 1-, 3-, and 5-year OS rates were 88, 72, and 59 %, respectively. After R0 resection, the 1-, 3-, and 5-year DFS rates were 93, 74, and 56 %, respectively. A multivariate analysis of the significant variables showed that only the modified Glasgow prognostic scores (p < 0.001) and PI (p < 0.001) were independently associated with OS. Regarding DFS, multivariate analysis of the significant variables showed that the modified Glasgow prognostic score (p = 0.002) and prognostic index (p < 0.001) were independently associated with DFS.

Conclusions: The results of this study show that modified Glasgow prognostic score and prognostic index are independent predictors of OS and DFS in patients with gastric cancer.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • C-Reactive Protein / metabolism
  • CA-19-9 Antigen / blood
  • Carcinoembryonic Antigen / blood
  • Disease-Free Survival
  • Female
  • Humans
  • Inflammation / blood*
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Neoplasm, Residual
  • Neutrophils*
  • Platelet Count
  • Predictive Value of Tests
  • Preoperative Care
  • Retrospective Studies
  • Serum Albumin / metabolism
  • Stomach Neoplasms / blood*
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / surgery
  • Survival Rate

Substances

  • CA-19-9 Antigen
  • Carcinoembryonic Antigen
  • Serum Albumin
  • C-Reactive Protein